Park et al. found that naringenin could diminish PRDX1 expression in pancreatic cancer cells, escalate ROS levels in cancer cells, and subsequently upregulate apoptosis signal-regulated kinase 1 (ASK1) to induce apoptosis 77. This evidence concerns the gene MAP3K5 and cancer.